Form 8-K - Current report:
SEC Accession No. 0001104659-25-093436
Filing Date
2025-09-25
Accepted
2025-09-25 17:23:28
Documents
16
Period of Report
2025-09-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2526946d1_8k.htm   iXBRL 8-K 39376
2 EXHIBIT 1.1 tm2526946d1_ex1-1.htm EX-1.1 212508
3 EXHIBIT 5.1 tm2526946d1_ex5-1.htm EX-5.1 13225
7 GRAPHIC tm2526946d1_ex5-1img001.jpg GRAPHIC 4070
8 GRAPHIC tm2526946d1_ex5-1img002.jpg GRAPHIC 2589
  Complete submission text file 0001104659-25-093436.txt   497961

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA imrx-20250924.xsd EX-101.SCH 3023
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE imrx-20250924_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imrx-20250924_pre.xml EX-101.PRE 22364
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2526946d1_8k_htm.xml XML 3848
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40675 | Film No.: 251344807
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)